SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?


To: DR. BOND who wrote (870)11/22/1997 12:19:00 PM
From: Tunica Albuginea  Respond to of 7041
 
Dr.BOND, it would appear to me that from a strictly scientific gggg
point of view your comments and impressions are well taken and as ususal very thought full.Food for thought as they say; for this weekend.

I am going to take this opportunity now to retire ( temporarily that is , ggg ) from the Zona thread, and move on to greener Vivus pastures.

Have a good weekend all and enjoy.Monday brings a new and
exciting market day.

TA



To: DR. BOND who wrote (870)11/22/1997 3:10:00 PM
From: Dauntless  Read Replies (1) | Respond to of 7041
 
It certainly has raised a flag for me. It has reminded that me that the market is driven by emotion more than logic & that even a pissant like ASHOLIO can cause enough unfounded panic to affect the stock price.

Of course I agree that the FDA may not approve Vasomax. I just wish that some people on this thread & other media wouldn't knowingly throw crap against the wall.

My confidence in Zonagen is unshaken - but I admit that the stock price may be in for short term fluctuations.



To: DR. BOND who wrote (870)11/23/1997 9:54:00 PM
From: Anaxagoras  Read Replies (1) | Respond to of 7041
 
<<Why hasn't the ANALYST AT VOLPE Publicly Supported Zona during all this controversy?>>

Jeeze, you step away for a few days and all heck breaks loose.

Bond, I haven't verified this, but I believe s/he has. On the conference call I believe that one participant mentioned that on the 17th of November a Volpe analyst had released an updated report on Schering mentioning that SGP was an "accumulate" based on the prospects of their recent deal with ZONA. Note, I am reporting what I believe I heard and I have not verified this information; I am merely reporting what I believe I heard.

It is however disappointing that they haven't been more aggressive in their support- likewise with SGP.

Golly, I don't even own any of this stock yet, but there sure is a lot of misinformation out there; frightening stuff, these threads.

Anaxagoras